These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1375677)

  • 1. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Zingarelli B; Ioculano MP; Campo GM; Calapai G; Saitta A; Urna G; Sardella A; Spignoli G
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):115-9. PubMed ID: 1375677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
    Squadrito F; Sturniolo R; Altavilla D; Santoro G; Campo GM; Arena A; Caputi AP
    Eur J Pharmacol; 1991 Jan; 192(1):47-53. PubMed ID: 2040364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Squadrito G; Campo GM; Serranò M; Sardella A; Urna G; Spignoli G
    Eur J Pharmacol; 1995 Nov; 286(1):31-9. PubMed ID: 8566149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splanchnic artery occlusion shock: vinblastine-induced leukopenia reduces tumour necrosis factor and thromboxane A2 formation, and increases survival rate.
    Canale P; Squadrito F; Zingarelli B; Altavilla D; Ioculano M; Campo GM; Caputi AP
    Pharmacol Res; 1993; 27(1):61-71. PubMed ID: 8456059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Ioculano M; Calapai G; Zingarelli B; Saitta A; Campo GM; Rizzo A; Caputi AP
    Circ Shock; 1992 Jul; 37(3):236-44. PubMed ID: 1423915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats.
    Sturniolo R; Squadrito F; Altavilla D; Trimarchi GR; Prosdocimi M; Caputi AP
    Circ Shock; 1989 Jul; 28(3):267-77. PubMed ID: 2766481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thromboxane biosynthesis in splanchnic ischemia shock.
    Oei HH; Zoganas HC; Sakane Y; Robson RD; Glenn TM
    Circ Shock; 1986; 18(2):95-106. PubMed ID: 3753907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
    Halushka PV; Cook JA; Wise WC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal and arterial plasma thromboxane and prostacyclin levels in shock: effects of indomethacin.
    Mózes T; Wieszt E
    J Surg Res; 1989 Dec; 47(6):482-6. PubMed ID: 2511379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Ferlito M; Deodato B; Arlotta M; Minutoli L; Campo GM; Bova A; Quartarone C; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
    Furlan LE; Johnson G; Siegfried M; Lefer AM
    J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
    Anderegg K; Anzeveno P; Cook JA; Halushka PV; McCarthy J; Wagner E; Wise WC
    Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splanchnic artery occlusion shock in the rat: effects of the calcium entry blockers nimodipine and verapamil.
    Sturniolo R; Altavilla D; Berlinghieri MC; Squadrito F; Caputi AP
    Circ Shock; 1988; 24(1):43-53. PubMed ID: 3345594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N; Lefer AM
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Ferlito M; Campo GM; Arlotta M; Grimaldi S; Quartarone C; Saitta A; Caputi AP
    Br J Pharmacol; 1999 May; 127(2):498-504. PubMed ID: 10385251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
    Zingarelli B; Squadrito F; Ioculano M; Altavilla D; Bussolino F; Campo GM; Caputi AP
    Eur J Pharmacol; 1992 Nov; 222(1):13-9. PubMed ID: 1468489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs.
    Matsumoto Y; Ochi H; Aihara K; Inui J; Ikegami K
    Eur J Pharmacol; 1992 Mar; 213(2):167-70. PubMed ID: 1521557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.